NCT00413972
Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)
See it on ClinicalTrials.gov β389 people
63.2%
36.8%
246 womenmiddle line = equal numbers143 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2006-11
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 18 Years β 75 Years
- Average age
- mean 58.2 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
βWomen who are pregnant or nursing.β
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
βWomen of childbearing potential (includes women who are less than 1 year postmenopausal and women who become sexually active) must be using an acceptable method of birth control.β
- No hormonal birth control
Women on the pill, patch, ring, shot, implant or hormonal IUD could not join.
βFemale subject receiving hormonal therapy, including hormone replacement, any estrogen antagonist/agonist, or oral contraceptives.β
- No hormone therapy
Women taking menopause hormones or gender-affirming hormones could not join.
ββ¦\] above upper limit of normal). Subjects with a history of hypothyroidism who are on a stable therapy of thyroid hormone replacement for at least 6 weeks are eligible for enrollment if TSH levels are within normal limits before enrollment.β
- Only women past menopause
Women who could still get pregnant were turned away.
βWomen of childbearing potential (includes women who are less than 1 year postmenopausal and women who become sexually active) must be using an acceptable method of birth control.β
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
βSubjects whose body mass index (BMI=weight \[kg\]/height2 \[m\]) is \>=30 kg/m2 at Visit 3 (Baseline Visit).β
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
βCongestive heart failure defined by NYHA as Class III or IV.β
- No diabetes
Women with diabetes were turned away.
βUncontrolled (as determined by fasting glucose \>180 mg/mL or HbA1c \>9%) or newly diagnosed (within 1 month of study entry) diabetes mellitus.β
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
βHistory of mental instability, drug/alcohol abuse within the past 5 years, or major psychiatric illness not adequately controlled and stable on pharmacotherapy.β
- No cancer
Women with current or past cancer were turned away.
βCancer within the past 5 years (except for successfully treated basal and squamous cell carcinomas).β
Study titles and rules are shown in their original English.